Diagnostic Center | November 15, 2023
Teva, Royalty Pharma collaborate to further accelerate Olanzapine LAI program
Phase 3 data expected in the second half of 2024
Phase 3 data expected in the second half of 2024
The company has raised US$4.5 million in funding for its AI operating system
he company posted total income during Q2 FY24 at Rs. 12.86 crore
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
The initiative will focus on advocating for cleaner air
RHTC will address a long-standing healthcare access issue for all the local population
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
hey were educated about the 7- step hand-washing technique trainings
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Subscribe To Our Newsletter & Stay Updated
